Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction-associated fatty liver disease and cardiovascular diseases
Metabolic dysfunction-associated fatty liver disease (MAFLD) is an increasingly common liver disease worldwide. MAFLD is diagnosed based on the presence of steatosis on images, histological findings, or serum marker levels as well as the presence of at least one of the three metabolic features: over...
Saved in:
Published in | Clinical and molecular hepatology Vol. 30; no. 1; pp. 16 - 36 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | Korean |
Published |
대한간학회
01.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Metabolic dysfunction-associated fatty liver disease (MAFLD) is an increasingly common liver disease worldwide. MAFLD is diagnosed based on the presence of steatosis on images, histological findings, or serum marker levels as well as the presence of at least one of the three metabolic features: overweight/obesity, type 2 diabetes mellitus, and metabolic risk factors. MAFLD is not only a liver disease but also a factor contributing to or related to cardiovascular diseases (CVD), which is the major etiology responsible for morbidity and mortality in patients with MAFLD. Hence, understanding the association between MAFLD and CVD, surveillance and risk stratification of MAFLD in patients with CVD, and assessment of the current status of MAFLD management are urgent requirements for both hepatologists and cardiologists. This Taiwan position statement reviews the literature and provides suggestions regarding the epidemiology, etiology, risk factors, risk stratification, nonpharmacological interventions, and potential drug treatments of MAFLD, focusing on its association with CVD. (Clin Mol Hepatol 2024;30:16-36) |
---|---|
AbstractList | Metabolic dysfunction-associated fatty liver disease (MAFLD) is an increasingly common liver disease worldwide. MAFLD is diagnosed based on the presence of steatosis on images, histological findings, or serum marker levels as well as the presence of at least one of the three metabolic features: overweight/obesity, type 2 diabetes mellitus, and metabolic risk factors. MAFLD is not only a liver disease but also a factor contributing to or related to cardiovascular diseases (CVD), which is the major etiology responsible for morbidity and mortality in patients with MAFLD. Hence, understanding the association between MAFLD and CVD, surveillance and risk stratification of MAFLD in patients with CVD, and assessment of the current status of MAFLD management are urgent requirements for both hepatologists and cardiologists. This Taiwan position statement reviews the literature and provides suggestions regarding the epidemiology, etiology, risk factors, risk stratification, nonpharmacological interventions, and potential drug treatments of MAFLD, focusing on its association with CVD. (Clin Mol Hepatol 2024;30:16-36) |
Author | Jia-horng Kao Pin-nan Cheng Chun-jen Liu Tsung-hsien Lin Wei-ting Chang Chi-yi Chen Chern-en Chiang Tzung-dau Wang Han-chieh Lin Chia-chi Wang Cheng-yuan Peng Yi-heng Li Wen-jone Chen Ting-hsing Chao Chih-lin Lin Charles Jia-yin Hou Yi-hsiang Huang Ming-lung Yu Jee-fu Huang Chao-yung Wang Chung-lieh Hung Chun-yen Lin Ping-yen Liu Yen-wen Wu Ming-ling Chang |
Author_xml | – sequence: 2 fullname: Pin-nan Cheng – sequence: 3 – sequence: 4 fullname: Wen-jone Chen – sequence: 5 fullname: Charles Jia-yin Hou – sequence: 6 fullname: Chih-lin Lin – sequence: 7 fullname: Ming-ling Chang – sequence: 8 fullname: Chia-chi Wang – sequence: 9 fullname: Wei-ting Chang – sequence: 10 fullname: Chao-yung Wang – sequence: 11 fullname: Chun-yen Lin – sequence: 12 fullname: Chung-lieh Hung – sequence: 13 fullname: Cheng-yuan Peng – sequence: 14 fullname: Ming-lung Yu – sequence: 15 fullname: Ting-hsing Chao – sequence: 16 fullname: Jee-fu Huang – sequence: 17 fullname: Yi-hsiang Huang – sequence: 18 fullname: Chi-yi Chen – sequence: 19 fullname: Chern-en Chiang – sequence: 20 fullname: Han-chieh Lin – sequence: 21 fullname: Yi-heng Li – sequence: 22 fullname: Tsung-hsien Lin – sequence: 23 fullname: Jia-horng Kao – sequence: 24 fullname: Tzung-dau Wang – sequence: 25 fullname: Ping-yen Liu – sequence: 26 fullname: Yen-wen Wu – sequence: 27 fullname: Chun-jen Liu |
BookMark | eNp9jk1OwzAQhS1UJAr0BGzmApFKkjZhiSoQC3btgl01tcdlhGNXHqcoZ-RSpCF02dX8fG_em1s18cHTlZrmeV1leb34mPz3VV7fqJkI7-ZlWRXFY7mYqp8N8jd6eBYJmjFx8GBDhPRJsE6t6SDYYXjnI8VsVK97LaWBrTAaDi7sOxjhIQgPPpIwUUM-nR0b9Lj_W_WnDSXcBccaTCe29fp0leH4CRmwmPoQd0oGw0IoBOgN6CHziKJbh2ck9-raohOajfVOPby-bFZv2ReLbA-RG4zdtpwvl8VTVVymv9A4bGg |
ContentType | Journal Article |
DBID | HZB Q5X |
DatabaseName | KISS (Koreanstudies Information service system) (KSI Package) Korean Studies Information Service System (KISS) B-Type |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction-associated fatty liver disease and cardiovascular diseases |
EISSN | 2287-285X |
ExternalDocumentID | 4066397 |
GroupedDBID | 5-W 8JR 8XY 9ZL ACYCR ADBBV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK EBD EF. EMOBN GROUPED_DOAJ HYE HZB KQ8 M48 M~E OK1 Q5X RNS RPM SV3 |
ID | FETCH-kiss_primary_40663973 |
IEDL.DBID | M48 |
ISSN | 2287-2728 |
IngestDate | Tue Jan 23 02:14:41 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | Korean |
LinkModel | DirectLink |
MergedId | FETCHMERGED-kiss_primary_40663973 |
Notes | The Korean Association for the Study of the Liver |
PageCount | 21 |
ParticipantIDs | kiss_primary_4066397 |
PublicationCentury | 2000 |
PublicationDate | 20240101 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – month: 01 year: 2024 text: 20240101 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Clinical and molecular hepatology |
PublicationTitleAlternate | Clinical and Molecular Hepatology(대한간학회지) |
PublicationYear | 2024 |
Publisher | 대한간학회 |
Publisher_xml | – name: 대한간학회 |
SSID | ssib044733145 ssib018711622 ssj0000702593 |
Score | 4.649634 |
Snippet | Metabolic dysfunction-associated fatty liver disease (MAFLD) is an increasingly common liver disease worldwide. MAFLD is diagnosed based on the presence of... |
SourceID | kiss |
SourceType | Publisher |
StartPage | 16 |
SubjectTerms | Cardiovascular disease MAFLD Position statement Taiwan |
Title | Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction-associated fatty liver disease and cardiovascular diseases |
URI | https://kiss.kstudy.com/ExternalLink/Ar?key=4066397 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwbV1LTwIxEG6IB-PFqGhU1MzBcKvZR9myJ2MIhBjxBAk3UrbdhAiLsmuUi3_QP-VMtwuYcNmk28c0baf92vk6ZexeqtBPPKW5VJHmIhWoUlqlvJW0MRBrISO6jTx4jfoj8TxujWusIrG7Bsz3bu3oPanRav7w_bF-tBoSINzngQzaTafKodesqlvqo2-dcQchjf3BFvj7uE3wo63jOiHo6UJnX7NzuEQsYD32bmTgnI2QLt9ZfXon7NjBRngq-_mU1d6WZ-xw4AzjdfY7VLMvlcFOawPCUUB4B0QVXMMytYEX4mFwl9pRNimuY3mpdMQOLrKic4G9c0SHiJsSFxvODGVdmAJH0nyWgF7ntE5SLq5cTYyGVBUoZE6SwRmEQGUakn9c2CoqP2eNXnfY6XNqiMl76Q5jIgi1xDK8YAfZMjOXDOgJE7LYhp5KRWSSqacjLw70VLZj0_LNFavvK-F6_-8GOwoQSZTnHjfsoFh9mltEAsX0znYqfX-6f3XGvWk |
link.rule.ids | 315,786,790,2236 |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Taiwan+Association+for+the+Study+of+the+Liver-Taiwan+Society+of+Cardiology+Taiwan+position+statement+for+the+management+of+metabolic+dysfunction-associated+fatty+liver+disease+and+cardiovascular+diseases&rft.jtitle=Clinical+and+molecular+hepatology&rft.au=Pin-nan+Cheng&rft.au=Wen-jone+Chen&rft.au=Charles+Jia-yin+Hou&rft.au=Chih-lin+Lin&rft.date=2024-01-01&rft.pub=%EB%8C%80%ED%95%9C%EA%B0%84%ED%95%99%ED%9A%8C&rft.issn=2287-2728&rft.eissn=2287-285X&rft.volume=30&rft.issue=1&rft.spage=16&rft.externalDocID=4066397 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2287-2728&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2287-2728&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2287-2728&client=summon |